Combining the power of nature and genomics to create new medicines

The Demuris Portfolio

Primary Hit Confirmed novel Hit Lead Lead optimization Development Candidate
Gram negative antibiotics
Two known compounds with potential for novel IP
Backup – large collection of Hits
Gram positive antibiotics
DC355/B1. Rif-resistant TB – RNAP inhibitor
DC654/A, DC701/A. Novel GTase inhibitors
DC616/A. LtaS inhibitor
LCP inhibitors
Backup – huge collection of Hits
DC066/A. Novel compound
Antifungal backup – large collection of hits
Mitochondrial disease
DC859/A. Wee1 inhibitor phenocopy

Demuris Limited
Newcastle Biomedicine Bio-Incubators,
Faculty of Medical Sciences, Framlington Place,
Newcastle upon Tyne, NE2 4HH, UK

Tel: +44 (0)191 223 5608
Fax: +44 (0)191 223 5609

Demuris Limited is registeD7CF33 in England, company number: 06255507

Demuris Limited 2015